Drug Profile
Research programme: therapeutic agents - KineMed/Organon
Latest Information Update: 25 Jan 2010
Price :
$50
*
At a glance
- Originator KineMed; Organon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 12 Jul 2006 Preclinical trials in Undefined in Netherlands (unspecified route)
- 12 Jul 2006 Preclinical trials in Undefined in USA (unspecified route)